These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Gruhne B; Sompallae R; Masucci MG Oncogene; 2009 Nov; 28(45):3997-4008. PubMed ID: 19718051 [TBL] [Abstract][Full Text] [Related]
28. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641 [TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells. Harris RS; Croom-Carter DS; Rickinson AB; Neuberger MS J Virol; 2001 Nov; 75(21):10488-92. PubMed ID: 11581418 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. Allday MJ; Crawford DH; Thomas JA J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171 [TBL] [Abstract][Full Text] [Related]
32. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies. Gutierrez MI; Bhatia K; Magrath I Leuk Res; 1993 Mar; 17(3):285-9. PubMed ID: 8383779 [TBL] [Abstract][Full Text] [Related]
33. Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood. Shatzer A; Ali MA; Chavez M; Dowdell K; Lee MJ; Tomita Y; El-Hariry I; Trepel JB; Proia DA; Cohen JI Leuk Lymphoma; 2017 Apr; 58(4):923-931. PubMed ID: 27686857 [TBL] [Abstract][Full Text] [Related]
34. EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma. Ruf IK; Rhyne PW; Yang H; Borza CM; Hutt-Fletcher LM; Cleveland JL; Sample JT Curr Top Microbiol Immunol; 2001; 258():153-60. PubMed ID: 11443860 [No Abstract] [Full Text] [Related]
36. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle. Evans TJ; Jacquemin MG; Farrell PJ Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099 [TBL] [Abstract][Full Text] [Related]
37. Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells. Kuhn-Hallek I; Sage DR; Stein L; Groelle H; Fingeroth JD Blood; 1995 Mar; 85(5):1289-99. PubMed ID: 7858259 [TBL] [Abstract][Full Text] [Related]
38. An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A. Lee W; Hwang YH; Lee SK; Subramanian C; Robertson ES J Virol; 2001 Sep; 75(18):8556-68. PubMed ID: 11507201 [TBL] [Abstract][Full Text] [Related]
39. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663 [TBL] [Abstract][Full Text] [Related]